This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Dec. 11, 2012




















 



CDC sounds warning on more tainted NECC drugs
CIDRAP News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Further testing on three more products from New England Compounding Center has turned up extensive contamination in three more products, and federal officials are asking healthcare workers to be alert for more infections, though they stopped short of calling the situation an outbreak. In a Health Alert Network update, the CDC said some of the organisms found in unopened vials of NECC's betamethasone, cardioplegia and triamcinolone solutions can cause disease in humans. More



 Area and Association News


Register today for the AzPA Psychiatric Certificate Program
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Assessing, Monitoring, and Managing Patients with Psychiatric Disorders: Comprehensive Medication Therapy Management to Optimize Pharmaceutical Care Learn more.


Inaugural Southwest Pharmacy Symposium
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Become a Pharmacy A.C.E. — Advocate, Communicate, Educate. Saturday, Jan. 26, 2013. Learn more.


NCPA: Gallup Poll Finds Public Confidence in Pharmacists at Record High
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
National Community Pharmacists Association CEO B. Douglas Hoey, RPh, MBA, issued a statement in response to the annual Gallup survey regarding professional honesty and ethics. More

Shop Amazon.com and support AzPA
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Will you be shopping online at Amazon.com this holiday season? Bookmark the AzPA Amazon Affiliates page, and a portion of your purchases will be donated to AzPA.

Holiday shopping is upon us
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Remember to purchase your gift cards through AzPA and support pharmacy education in Arizona. Learn more.


Not an AzPA member? Join today
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings. With over 1,500 members, we are a leading association of pharmacists spreading the news and events of our industry. More

 Pharmacy Updates


Pharmacists in ED help cut drug errors
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Involving pharmacists in the hospital admission process can help cut down on transition medication errors and discrepancies, a pilot study suggested. When a pharmacy team interviewed patients in the emergency department about their routine medications, only 48 discrepancies were missed, compared with 1,547 missed by the admission nursing staff, according to Justin Hoppes, PharmD, of the Winchester Medical Center in Winchester, Va. More

Massachusetts pharmacists request changes in regulations adopted after meningitis outbreak
The Boston Globe    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Pharmacy industry executives in Massachusetts requested changes to emergency state regulations adopted in November in the wake of the national fungal meningitis outbreak. Under the new rules, specialty pharmacies similar to New England Compounding Center, the Massachusetts company whose contaminated drugs are blamed for the outbreak, are required to report to state regulators the volume of medications they are making and whether they have detected contamination in their laboratories. More

Congress investigating compounding pharmacy group
The Associated Press via USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
House lawmakers are investigating whether the industry group for compounding pharmacies coached the company responsible for a deadly outbreak of meningitis in dealing with regulators. The House Committee on Energy and Commerce sent a letter to the International Academy of Compounding Pharmacists requesting any documents it distributed to members about how to respond to state and federal health inspectors. More

 In the News


FDA drug approvals increase
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
TheFDA is on track to approve more than 30 new drugs this year — the most in eight years — partly because the pharmaceutical industry is speeding development of experimental drugs. As of the end of November, the agency approved 31 new types of drugs for diseases including cancer, multiple sclerosis, rheumatoid arthritis and HIV in addition to the first weight-loss drug approved in more than a decade. More

Opioid overdose focus of AMA/CDC education effort
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Both the federal government and organized medicine announced moves aimed at attacking the opioid addiction and overdose problems. The HHS announced that patients in U.S. addiction treatment programs will no longer have to wait a year to be eligible for therapy with buprenorphine. On Dec. 12, the American Medical Association and the CDC will host a joint webinar on unintentional opioid overdose. More

CDC: Flu season could be relatively severe
Nurse.com    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In contrast to last year's late-arriving and mild flu season, the upcoming season could be early and severe, officials with the CDC said. "We're seeing the beginning of the uptick start at least a month before we'd generally see it," said CDC Director Dr. Thomas Frieden, MPH. Among nurses, physicians and pharmacists, about 80 to 90 percent have been vaccinated, Frieden said. More

Researchers track drug reactions using social media
Pharmacy Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers are turning to Twitter, blogs and online discussions to track adverse drug reactions. According to West Virginia University's Research Highlights and a recent posting on ScienceDaily, the study results could determine whether a reaction database could be established for medical professionals and pharmaceutical companies. In addition, it could also be useful for establishing drug-drug interactions that cannot be pinpointed through testing or clinical trials. More

 Medication Updates


FDA expands Zytiga's use for late-stage prostate cancer
U.S. Food and Drug Administration    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The FDA recently expanded the approved use of Zytiga to treat men with late-stage castration-resistant prostate cancer prior to receiving chemotherapy. The FDA initially approved Zytiga in November 2011 for use in patients whose prostate cancer progressed after treatment with docetaxel, a chemotherapy drug. Zytiga is a pill that decreases the production of male sex hormone testosterone. More

Benzodiazepines linked to higher pneumonia risk
Nurse.com    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Benzodiazepines may increase the risk of contracting pneumonia by as much as 50 percent and also increase the risk of dying from it, according to a British study. The use of these drugs has been linked to a heightened risk of infections and death from sepsis in critically ill patients, and researchers wanted to investigate whether they had a similar impact on the risk of developing fatal pneumonia. More

Patent expiries trigger pain drugs battle
Financial Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Looming patent expiries on powerful pain medicines have triggered a battle for control of the $9 billion prescription market between pharmaceutical groups and competitors making generic versions of the drugs. Generic drug companies are lobbying the FDA for permission to sell copies of narcotic painkillers — even though concerns over the abuse of these drugs are rising and safer abuse-resistant versions are available. More


 

AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Content Editor, 469.420.2696   
Contribute news

Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Dec. 11, 2012
Dec. 4, 2012
Nov. 27, 2012
Nov. 20, 2012



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063